Global Genetic Disease Diagnosis Market Growth (Status and Outlook) 2023-2029
According to this study, the global Genetic Disease Diagnosis market size will reach US$ million by 2029.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Disease Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by product type:
Robotic Radiosurgery
Usage Of Molecular Target Agents
Others
Segmentation by Application:
Inherited Disorder Testing
Pharmacogenetic Testing (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Abbott Laboratories
Siemens Healthineers
Roche Diagnostics Corp
Bayer Diagnostics
Sysmex Corporation
Cephide
Bio-Rad Laboratories
Thermo Fisher Scientific
Illumina, Inc
Applied Biosystems
Transgenomic Inc
AutoGenomics
Please note: The report will take approximately 2 business days to prepare and deliver.
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Genetic Disease Diagnosis Key Players
- 4 Genetic Disease Diagnosis by Regions
- 5 United States
- 6 Europe
- 7 China
- 8 Rest of World
- 9 Market Drivers, Challenges and Trends
- 10 Key Investors in Genetic Disease Diagnosis
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook